Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hainan Shuangcheng Pharmaceuticals Co Ltd

+ Add to Watchlist

002693:CH

13.690 CNY 0.060 0.44%

As of 03:00:23 ET on 03/30/2015.

Snapshot for Hainan Shuangcheng Pharmaceuticals Co Ltd (002693)

Open: 13.680 Day's Range: 13.560 - 13.780 Volume: 8,079,751
Previous Close: 13.630 52wk Range: 5.733 - 14.450 1-Yr Rtn: +127.98%

Stock Chart for 002693

No chart data available.
  • 002693:CH 13.690
  • 1D
  • 1M
  • 1Y
13.630
Interactive 002693 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002693

Current P/E Ratio (ttm) 92.5909
Estimated P/E(12/2015) -
Relative P/E vs. SZASHR 1.9177
Earnings Per Share (CNY) (ttm) 0.1467
Est. EPS (CNY) (12/2015) -
Est. PEG Ratio -
Market Cap (M CNY) 5,499.90
Shares Outstanding (M) 405.00
30 Day Average Volume 9,003,122
Price/Book (mrq) 6.2049
Price/Sale (ttm) 34.4290
Dividend Indicated Gross Yield 0.49%
Cash Dividend (CNY) 0.0667
Dividend Ex-Date 03/10/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002693

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002693

Hainan Shuangcheng Pharmaceuticals Company Limited develops, manufactures and sells chemical synthesized peptide drugs. The Company's main products include thymalfasin, somatostatin, and thymopentin for injection.

Wang ChengdongChairman/PresidentWang YingpuVice Chairman/VP
Yuan JianlinVice PresidentLiu XiaobinVice President
More Company Profile & Key Executives for 002693

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil